510(k) Report

FDA product code · Ophthalmic

Lens, Intraocular, Phakic

MTAClass IIIPMA required2 decisions since 20048 recalls

2 FDA decisions since 2004. 8 recalls name this code, 0 of them Class I.

Data to Oct 25, 2026 (FDA decisions) Oct 12, 2026 (recalls) Sep 30, 2026 (MAUDE) refreshed weekly, last Nov 3, 2026 Download the data (CSV)

FIG. A — Illustration, ophthalmic panel

Twenty years of MTA at a glance: how often FDA decides these devices, how long 510(k) reviews take, how often they are recalled, and how many adverse event reports name the code.

FDA decisions per year · MTA

2in 2025

2008: 72009: 32010: 52011: 42012: 22013: 12014: 22015: 22017: 52018: 32019: 62020: 12021: 12022: 42024: 42025: 22026 (partial year): 2
2007high 7 (2008) · low 0 (2007)2026

2026 to Oct 25, outlined.

Median 510(k) review, days · MTA

Too few MTA 510(k)s in any year since 2007 to give a median.

Recalls per year · MTA

7in 2023

2023: 72026 (partial year): 1
2007high 7 (2023) · low 0 (2007)2026

Class I (0 since 2007) Class II/III not classified

Adverse event reports per year · MTA

655in 2025

2007: 42008: 2262009: 6012010: 5512011: 3112012: 5002013: 6962014: 7812015: 1,2792016: 1,4562017: 1,7962018: 1,7782019: 1,2362020: 1,4402021: 2,0632022: 1,9172023: 2,0762024: 2,1482025: 655
2007high 2,148 (2024) · low 4 (2007)2025

MAUDE reports naming product code MTA, not matched to any one device; reports are not rates.

View these four charts as a table
YearDecisionsMedian 510(k) review, daysRecalls (Class I)MAUDE reports
20070—04
20087—0226
20093—0601
20105—0551
20114—0311
20122—0500
20131—0696
20142—0781
20152—01,279
20160—01,456
20175—01,796
20183—01,778
20196—01,236
20201—01,440
20211—02,063
20224—01,917
20230—72,076
20244—02,148
20252—0655
20262—1—
FIG. 1 — MTA by year, 2007–2026Sources: FDA decision databases, recall and enforcement reports, MAUDE · Data through Oct 25, 2026

Planning a device in MTA? A 510(k) Report ranks candidate predicates in this code by lineage, citations and recall history, with the review-time outlook.

See the 510(k) Report